Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2018 1
2020 4
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

PubMed for Bookshelf ID: 5413206

8 results

Results by year

Filters applied: . Clear all
Page 1
Pemigatinib-Related Calcification in the Liver.
Yang X, Yang X, Zhao H. Yang X, et al. Am J Gastroenterol. 2023 Feb 1;118(2):201. doi: 10.14309/ajg.0000000000002037. Epub 2022 Sep 30. Am J Gastroenterol. 2023. PMID: 36191267 No abstract available.
Pemigatinib (Pemazyre) for cholangiocarcinoma.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2018 May 7;60(1546):e208-e209. Med Lett Drugs Ther. 2018. PMID: 33451178 No abstract available.
Pemigatinib: First Approval.
Hoy SM. Hoy SM. Drugs. 2020 Jun;80(9):923-929. doi: 10.1007/s40265-020-01330-y. Drugs. 2020. PMID: 32472305 Review.
INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models.
Liu PCC, Koblish H, Wu L, Bowman K, Diamond S, DiMatteo D, Zhang Y, Hansbury M, Rupar M, Wen X, Collier P, Feldman P, Klabe R, Burke KA, Soloviev M, Gardiner C, He X, Volgina A, Covington M, Ruggeri B, Wynn R, Burn TC, Scherle P, Yeleswaram S, Yao W, Huber R, Hollis G. Liu PCC, et al. PLoS One. 2020 Apr 21;15(4):e0231877. doi: 10.1371/journal.pone.0231877. eCollection 2020. PLoS One. 2020. PMID: 32315352 Free PMC article.
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study.
Abou-Alfa GK, Sahai V, Hollebecque A, Vaccaro G, Melisi D, Al-Rajabi R, Paulson AS, Borad MJ, Gallinson D, Murphy AG, Oh DY, Dotan E, Catenacci DV, Van Cutsem E, Ji T, Lihou CF, Zhen H, Féliz L, Vogel A. Abou-Alfa GK, et al. Lancet Oncol. 2020 May;21(5):671-684. doi: 10.1016/S1470-2045(20)30109-1. Epub 2020 Mar 20. Lancet Oncol. 2020. PMID: 32203698 Free PMC article. Clinical Trial.